It is exciting to enter into a licensing collaboration with ATUM for the Leap-In transposon platform. ?? ?? ?? We believe based on ATUM's Leap-In Transposon platform, combined with Aton's years of experience in the development and manufacture of large-molecule biologics, we will accelerate client's pipelines to the market with high-quality and efficient cell line development and scale-up services.
What's in a name? ATUM and Aton Biotech separated at birth. Only our mom can tell us apart. We're proud to announce that Aton has licensed our Leap-In transposon platform. Forward-thinking companies like Aton recognize the importance of accessing cutting-edge technologies to advance therapeutic development. People who made it happen: #Wei_Huang, Yanling Wang, Alexa Foster, Selena Larkin, Mario Pereira (hiding behind banner)